Context Therapeutics is trading at $0.49, up +5.11% on August 13, 2026, as softer-than-expected July PPI and slightly higher jobless claims reduced expectations for a September Federal Reserve rate hike.
- The Nasdaq Composite is up 0.58%, exceeding the 0.5% threshold for a meaningful market trend.
- No clear company-specific announcement was identified during the session; the latest major update was second-quarter reporting on August 5.